Genteract Email Format
Biotechnology ResearchCalifornia, United States2-10 Employees
Genteract is a biotechnology research company based in San Francisco, California. It focuses on identifying gene-environment interactions with substantially greater statistical power, enabling predictions about how an individual’s genetics may influence their response to a drug. The company emphasizes applications across drug repositioning, clinical trial optimization, drug response prediction, and oncology, aiming to tailor therapies and improve outcomes by focusing on genetically defined patient subgroups. Its work targets pharmaceutical developers, clinical researchers, and payers seeking more efficient trial designs, better patient stratification, and improved therapeutic efficacy with fewer adverse effects. Current information indicates a small team focused on data-driven analysis of clinical trial data and medical records to unlock previously hidden value in patient cohorts and trial results. A recent brief note highlights opportunities to analyze clinical trial or EMR data to uncover actionable insights for drug development and treatment strategies.